CHGCY:OTCMKTS
Chugai Pharmaceutical ADR
19,10 US$
arrow_downward
-0,62%(-0,12) 1D
14 ოქტ, 11:15:57 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCY...
Open
18,56 US$
High
19,15 US$
Low
18,33 US$
Mkt. cap
10,14 ტრლ.
Avg. vol.
318,06 ათ.
Volume
101,57 ათ.
52-wk high
34,84 US$
52-wk low
18,33 US$
Beta
0,56
Shares outstanding
3,36 მლრდ.
No. of employees
5 ათ.
Open
18,56 US$
High
19,15 US$
Low
18,33 US$
Mkt. cap
10,14 ტრლ.
Avg. vol.
318,06 ათ.
Volume
101,57 ათ.
52-wk high
34,84 US$
52-wk low
18,33 US$
Beta
0,56
Shares outstanding
3,36 მლრდ.
No. of employees
5 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
·
6 საათის წინ
Chugai reports vamikibart data for Chugai Pharmaceutical stock
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical ADR
CEOოსამუ ოკუდა
Employees5,1 ათ.
Founded10 მარ. 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp